According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.

Researchers evaluated links between lifestyle and dietary index scores and risk of death in a prospective, multiethnic cohort of men diagnosed with non-metastatic prostate cancer.

A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

For that trial, the eligible patients were the ones who had metastatic castration-resistant prostate cancer with at least ... advanced Gleason score 8 to 10, and metastatic site distribution ...

and >8, respectively. This was performed on the GGG of radical prostatectomies. Should Gleason Score at the Positive Surgical Margin appear on the Pathology Report for Robot-Assisted Radical ...

The primary outcome was detection rate of Gleason Grade Group (GGG) 2 or higher prostate cancer. Secondary outcomes included complications ... antimicrobials through medical and agricultural use. 8,9 ...

Notably, PSMA PET staging in high-risk prostate cancer detects M1 disease in 15-27% of ... However, most patients had more favorable disease features—primarily Gleason 7, with <20% having Gleason 8-10 ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...

Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher ...

Microultrasonography-guided prostate biopsy proved noninferior to MRI/conventional ultrasound-fusion (MRI/US-fusion) imaging ...